DANIEL DONOFRIO: Open Payments
NPI 1710090915 · SAINT AUGUSTINE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$663 in 25 payments from 14 companies in 2025. Trend: 2023 $1,271 · 2024 $1,354 · 2025 $663
Food & beverage: $663
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $309 |
| Janssen Pharmaceuticals, Inc | 3 | $75 |
| Medtronic, Inc. | 1 | $56 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Optinose US, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $21 |
| Lundbeck LLC | 1 | $20 |
| Astellas Pharma US Inc | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
Products named: Wegovy, Ozempic, SPRAVATO, REXULTI, INTERSTIM, Xhance, ELIQUIS, Veozah.
Industry payments across FL — which companies pay providers there.
